Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Imaging in prostate cancer staging: present role and future perspectives.
Pinto F, Totaro A, Palermo G, Calarco A, Sacco E, D'Addessi A, Racioppi M, Valentini A, Gui B, Bassi P.
Urol Int. 2012;88(2):125-36. Epub 2012 Jan 27.
Related citations
Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience.
Philippou P, Yap T, Chinegwundoh F.
Urol Int. 2012;88(2):137-44. Epub 2012 Jan 24.
Prediction of biochemical recurrence after radical prostatectomy using peritumoral lymphatic vessel density in biopsy specimens in patients with localized prostate cancer.
Kuroda K, Horiguchi A, Asano T, Tasaki S, Yoshii H, Sato A, Asakuma J, Ito K, Seguchi K, Sumitomo M, Asano T.
Urol Int. 2012;88(1):18-24. Epub 2012 Jan 4.
Investigative clinical study on prostate cancer part VI: Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
Porcaro AB, Migliorini F, Petrozziello A, Sava T, Romano M, Caruso B, Cocco C, Ghimenton C, Zecchinini Antoniolli S, Lacola V, Rubilotta E, Monaco C, Comunale L.
Urol Int. 2012;88(2):150-7. Epub 2011 Dec 23.
Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer.
Divrik RT, Türkeri L, Şahin AF, Akdoğan B, Ateş F, Çal Ç, Baltacı S; Urooncology Association.
Urol Int. 2012;88(1):25-33. Epub 2011 Dec 17.
Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Gbenou MC, Peltier A, Addla SK, Lemort M, Bollens R, Larsimont D, Roumeguère T, Schulman CC, van Velthoven R.
Urol Int. 2012;88(1):12-7. Epub 2011 Oct 15.
Clinically significant urethral stricture and/or subclinical urethral stricture after high-intensity focused ultrasound correlates with disease-free survival in patients with localized prostate cancer.
Komura K, Inamoto T, Black PC, Fujisue Y, Katsuoka Y, Watsuji T, Azuma H.
Urol Int. 2011;87(3):276-81. Epub 2011 Sep 10.
The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
Gyftopoulos K, Vourda K, Sakellaropoulos G, Perimenis P, Athanasopoulos A, Papadaki E.
Urol Int. 2011;87(4):464-9. Epub 2011 Sep 10.
Impact of metabolic syndrome on biochemical recurrence of prostate cancer after radical prostatectomy.
Castillejos-Molina R, Rodríguez-Covarrubias F, Sotomayor M, Gómez-Alvarado MO, Villalobos-Gollás M, Gabilondo F, Feria-Bernal G.
Urol Int. 2011;87(3):270-5. Epub 2011 Aug 27.
Feasibility of tri-weekly docetaxel-based chemotherapy for elderly patients (age 75 and older) with castration-resistant prostate cancer.
Takaha N, Okihara K, Kamoi K, Hongo F, Iwata T, Yano K, Ueda T, Takeuchi I, Yamada T, Kawauchi A, Miki T.
Urol Int. 2011;87(3):263-9. Epub 2011 Aug 26.
Outcome of antegrade radical prostatectomy with intended wide resection in prostate cancer patients with a preoperative serum PSA level >100 ng/ml.
Urakami S, Yonese J, Yamamoto S, Yuasa T, Kitsukawa S, Numao N, Kubo Y, Ito M, Sukegawa G, Yasuda Y, Ishikawa Y, Fukui I.
Urol Int. 2011;87(2):175-81. Epub 2011 Aug 18.
The value of contrast-enhanced transrectal ultrasound in predicting the nature of prostate diseases and the Gleason score of prostate cancer by a subjective blood flow grading scale.
Zhao HW, Luo JH, Xu HX, Wang DH, Lai YR, Chen MN, Lv JY, Xie XY, Lu MD, Chen W.
Urol Int. 2011;87(2):165-70. Epub 2011 Aug 11.
Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy?
Pepe P, Aragona F.
Urol Int. 2011;87(2):171-4. Epub 2011 Jul 19.
Optimal duration of androgen deprivation in combination with radiation therapy for Japanese men with high-risk prostate cancer.
Takaha N, Okihara K, Kamoi K, Kimura Y, Yamada T, Kawauchi A, Kobayashi K, Yamazaki H, Nishimura T, Miki T.
Urol Int. 2011;87(1):28-34. Epub 2011 Jun 23.
Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study.
Rouse P, Shaw G, Ahmed HU, Freeman A, Allen C, Emberton M.
Urol Int. 2011;87(1):49-53. Epub 2011 Jun 22.
Lack of association of the genotype in the GNAS Fok I polymorphism and prostate cancer.
Eisenhardt A, Scherag A, Jöckel KH, Reis H, Rübben H, Siffert W.
Urol Int. 2011;87(1):80-6. Epub 2011 Jun 11.
Association between fibroblast growth factor receptor-4 gene polymorphism and risk of prostate cancer: a meta-analysis.
Liwei L, Chunyu L, Jie L, Ruifa H.
Urol Int. 2011;87(2):159-64. Epub 2011 May 28.
Getting personal with prostate cancer: adding new pieces to an incomplete jigsaw puzzle.
Farooqi AA, Bhatti S.
Urol Int. 2011;87(2):127-33. Epub 2011 Apr 30. Review.
Investigative clinical study on prostate cancer part IV: exploring functional relationships of total testosterone predicting free testosterone and total prostate-specific antigen in operated prostate cancer patients.
Porcaro AB, Petrozziello A, Migliorini F, Lacola V, Romano M, Sava T, Ghimenton C, Caruso B, Zecchini Antoniolli S, Rubilotta E, Monaco C, Comunale L.
Urol Int. 2011;86(4):399-406. Epub 2011 Apr 20.
Imaging in prostate cancer diagnosis: present role and future perspectives.
Pinto F, Totaro A, Calarco A, Sacco E, Volpe A, Racioppi M, D'Addessi A, Gulino G, Bassi P.
Urol Int. 2011;86(4):373-82. Epub 2011 Mar 2. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on